Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Younger and Older Subjects With Osteoarthritis Knee Pain
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Fulranumab (Primary)
- Indications Osteoarthritis; Pain
- Focus Adverse reactions
- Sponsors Amgen
- 23 Dec 2014 New trial record